Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits

European Heart Journal - Cardiovascular Pharmacotherapy

6 May 2020
Organised by: Logo
ESC Journals

Contributors

Gerasimos Siasos
Gerasimos Siasos

Author

National & Kapodistrian University of Athens Athens , Greece

Evangelos Oikonomou
Evangelos Oikonomou

Author

National & Kapodistrian University of Athens Athens , Greece

ESC 365 is supported by